Search

Your search keyword '"Greer, Julia B."' showing total 197 results
Start Over Author "Greer, Julia B."
197 results on '"Greer, Julia B."'

2. Low serum trypsinogen levels in chronic pancreatitis: Correlation with parenchymal loss, exocrine pancreatic insufficiency, and diabetes but not CT-based cambridge severity scores for fibrosis

Author

Zhan, Wei, Akshintala, Venkata, Greer, Phil J., Greer, Julia B., Alkaade, Samer, Anderson, Michelle A., Muniraj, Thiruvengadam, Papachristou, Georgios I., Sandhu, Bimaljit S., Slivka, Adam, Wilcox, C. Mel, Bellin, Melena D., Singh, Vikesh K., Yadav, Dhiraj, Brand, Randall E., and Whitcomb, David C.

Published
2020
Full Text
View/download PDF

21. Multicenter Approach to Recurrent Acute and Chronic Pancreatitis in the United States: The North American Pancreatitis Study 2 (NAPS2)

Author

Whitcomb, David C., Yadav, Dhiraj, Adam, Slivka, Hawes, Robert H., Brand, Randall E., Anderson, Michelle A., Money, Mary E., Banks, Peter A., Bishop, Michèle D., Baillie, John, Sherman, Stuart, DiSario, James, Burton, Frank R., Gardner, Timothy B., Amann, Stephen T., Gelrud, Andres, Lo, Simon K., DeMeo, Mark T., Steinberg, William M., Kochman, Michael L., Etemad, Babak, Forsmark, Christopher E., Elinoff, Beth, Greer, Julia B., O'Connell, Michael, Lamb, Janette, and Barmada, M. Michael

Published
2008
Full Text
View/download PDF

27. Alcohol Consumption, Cigarette Smoking, and the Risk of Recurrent Acute and Chronic Pancreatitis

Author

Yadav, Dhiraj, Hawes, Robert H., Brand, Randall E., Anderson, Michelle A., Money, Mary E., Banks, Peter A., Bishop, Michele D., Baillie, John, Sherman, Stuart, DiSario, James, Burton, Frank R., Gardner, Timothy B., Amann, Stephen T., Gelrud, Andres, Lawrence, Christopher, Elinoff, Beth, Greer, Julia B., OʼConnell, Michael, Barmada, Michael M., Slivka, Adam, and Whitcomb, David C.

Published
2009
Full Text
View/download PDF

32. Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients

Author

Greer, Julia B., primary, Greer, Phil, additional, Sandhu, Bimaljit S., additional, Alkaade, Samer, additional, Wilcox, C. Mel, additional, Anderson, Michelle A., additional, Sherman, Stuart, additional, Gardner, Timothy B., additional, Lewis, Michele D., additional, Guda, Nalini M., additional, Muniraj, Thiruvengadam, additional, Conwell, Darwin, additional, Cote, Gregory A., additional, Forsmark, Christopher E., additional, Banks, Peter A., additional, Tang, Gong, additional, Stello, Kim, additional, Gelrud, Andres, additional, Brand, Randall E., additional, Slivka, Adam, additional, Whitcomb, David C., additional, and Yadav, Dhiraj, additional

Published
2018
Full Text
View/download PDF

35. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis

Author

Raina, Amit, Krasinskas, Alyssa M., Greer, Julia B., Lamb, Janette, Fink, Erin, Moser, A. James, Zeh, Herbert J., III, Slivka, Adam, and Whitcomb, David C.

Subjects
Pancreatic cancer -- Diagnosis, Pancreatic cancer -- Genetic aspects, Immunoglobulin G -- Research, Immunoglobulin G -- Physiological aspects, Pancreatitis -- Health aspects
Abstract

Context.--Autoimmune pancreatitis is an uncommon, inflammatory disease of the pancreas that presents with clinical features, such as painless jaundice and a pancreatic mass, similar to those caused by pancreatic cancer. Patients with autoimmune pancreatitis frequently have elevated serum immunoglobulin G fraction 4 (IgG4) levels, and their pancreatic tissue may show IgG4-positive plasma cell infiltration. It is imperative to differentiate autoimmune pancreatitis from pancreatic cancer because autoimmune pancreatitis typically responds to corticosteroid treatment. A previous Japanese study reported that serum IgG4 greater than 135 mg/dL was 97% specific and 95% sensitive in predicting autoimmune pancreatitis. Objective.--To prospectively measure serum IgG4 levels in pancreatic cancer patients to ascertain whether increased levels might be present in this North American population. Design.--We collected blood samples and phenotypic information on 71 consecutive pancreatic cancer patients and 103 healthy controls who visited our clinics between October 2004 and April 2006. IgG4 levels were determined using a single radial immunodiffusion assay. A serum IgG4 level greater than 135 mg/dL was considered elevated. Results.--Five cancer patients had IgG4 elevation, with a mean serum IgG4 level of 160.8 mg/dL. None of our cancer patients with plasma IgG4 elevation demonstrated evidence of autoimmune pancreatitis. One control subject demonstrated elevated serum IgG4 unrelated to identified etiology. Conclusions.--As many as 7% of patients with pancreatic cancer have serum IgG4 levels above 135 mg/dL. In patients with pancreatic mass lesions and suspicion of cancer, an IgG4 level measuring between 135 and 200 mg/dL should be interpreted cautiously and not accepted as diagnostic of autoimmune pancreatitis without further evaluation., Autoimmune pancreatitis (AIP) is a newly classified and rare form of inflammatory pancreatic disease. It often occurs in the presence of other autoimmune disease and is characterized by lymphoplasmacytic inflammatory [...]

Published
2008

38. IBD LIVE Series—Case 7

Author

Click, Benjamin H., primary, Greer, Julia B., additional, Regueiro, Miguel D., additional, Hartman, Douglas J., additional, Davis, Peter L., additional, Siegel, Corey A., additional, Herfarth, Hans H., additional, Rosh, Joel R., additional, Shah, Samir A., additional, Koltun, Walter A., additional, Binion, David G., additional, Baidoo, Leonard, additional, and Szigethy, Eva, additional

Published
2017
Full Text
View/download PDF

41. Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients.

Author

Greer, Julia B., Greer, Phil, Sandhu, Bimaljit S., Alkaade, Samer, Wilcox, C. Mel, Anderson, Michelle A., Sherman, Stuart, Gardner, Timothy B., Lewis, Michele D., Guda, Nalini M., Muniraj, Thiruvengadam, Conwell, Darwin, Cote, Gregory A., Forsmark, Christopher E., Banks, Peter A., Tang, Gong, Stello, Kim, Gelrud, Andres, Brand, Randall E., and Slivka, Adam

Published
2019
Full Text
View/download PDF

43. IBD LIVE Case Series—Case 6

Author

Rajan, Dhyan, primary, Greer, Julia B., additional, Regueiro, Miguel D., additional, Baidoo, Leonard, additional, Binion, David G., additional, Herfarth, Hans H., additional, Siegel, Corey A., additional, Hartman, Douglas J., additional, Farraye, Francis A., additional, Koutroubakis, Ioannis E., additional, Brand, Myron H., additional, Williams, Emmanuelle D., additional, Goyal, Alka, additional, and Cross, Raymond K., additional

Published
2016
Full Text
View/download PDF

44. IBD LIVE Case Series–Case 5

Author

Abdul-Baki, Heitham, primary, Greer, Julia B., additional, Binion, David G., additional, Kermanshahi, Taher Reza, additional, Brand, Myron H., additional, Williams, Emmanuelle D., additional, Bensen, Steven P., additional, Holubar, Stefan D., additional, Keljo, David J., additional, and Regueiro, Miguel D., additional

Published
2016
Full Text
View/download PDF

46. IBD LIVE Case Series–Case 4

Author

Gulati, Abhishek, primary, Clarke, Kofi, additional, Greer, Julia B., additional, Binion, David G., additional, Brand, Myron H., additional, Farraye, Francis A., additional, Cross, Raymond K., additional, Baidoo, Leonard, additional, Schraut, Wolfgang H., additional, Hartman, Douglas J., additional, and Regueiro, Miguel D., additional

Published
2016
Full Text
View/download PDF

47. Mo1862 A Virtual Case Management Program for a New Era of Healthcare: The Inflammatory Bowel Disease Live Inter-Institutional and Interdisciplinary Videoconference Education (IBD LIVE) Series Improves Quality of Care

Author

Regueiro, Miguel, primary, Greer, Julia B., additional, Cross, Raymond, additional, Williams, Emmanuelle D., additional, Tinsley, Andrew, additional, Herfarth, Hans H., additional, Siegel, Corey A., additional, Brand, Myron H., additional, Goyal, Alka, additional, Keljo, David J., additional, Binion, David G., additional, Farraye, Francis A., additional, Iskandar, Heba, additional, Shah, Samir A., additional, Hashash, Jana G., additional, Schraut, Wolfgang H., additional, Hartman, Douglas J., additional, Davis, Peter L., additional, Szigethy, Eva, additional, and Watson, Andrew R., additional

Published
2016
Full Text
View/download PDF

48. Endoscopist factors that influence serrated polyp detection: a multicenter study.

Author

Crockett, Seth D., Gourevitch, Rebecca A., Morris, Michele, Carrell, David S., Rose, Sherri, Zhuo Shi, Greer, Julia B., Schoen, Robert E., Mehrotra, Ateev, and Shi, Zhuo

Subjects
COLON polyps, COLON cancer, COLONOSCOPY
Abstract

Background: Serrated polyps are important colorectal cancer precursors that are variably detected during colonoscopy. We measured serrated polyp detection rate (SPDR) in a large, multicenter, cross-sectional study of colonoscopy quality to identify drivers of SPDR variation.Methods: Colonoscopy and pathology reports were collected for a 2-year period (10/2013-9/2015) from four sites across the United States. Data from reports, including size, location, and histology of polyps, were abstracted using a validated natural language processing algorithm. SPDR was defined as the proportion of colonoscopies with ≥ 1 serrated polyp (not including hyperplastic polyps). Multivariable logistic regression was performed to determine endoscopist characteristics associated with serrated polyp detection.Results: A total of 104 618 colonoscopies were performed by 201 endoscopists who varied with respect to specialty (86 % were gastroenterologists), sex (18 % female), years in practice (range 1 - 51), and number of colonoscopies performed during the study period (range 30 - 2654). The overall mean SPDR was 5.1 % (SD 3.8 %, range 0 - 18.8 %). In multivariable analysis, gastroenterology specialty training (odds ratio [OR] 1.89, 95 % confidence interval [CI] 1.33 - 2.70), fewer years in practice (≤ 9 years vs. ≥ 27 years: OR 1.52, 95 %CI 1.14 - 2.04)], and higher procedure volumes (highest vs. lowest quartile: OR 1.77, 95 %CI 1.27 - 2.46)] were independently associated with serrated polyp detection.Conclusions: Gastroenterology specialization, more recent completion of training, and greater procedure volume are associated with serrated polyp detection. These findings imply that both repetition and training are likely to be important contributors to adequate detection of these important cancer precursors. Additional efforts to improve SPDR are needed. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

50. IBD LIVE Case Series—Case 3

Author

Sunseri, Whitney M., primary, Kugathasan, Subra, additional, Keljo, David J., additional, Greer, Julia B., additional, Ranganathan, Sarangarajan, additional, Cross, Raymond K., additional, Siegel, Corey A., additional, and Regueiro, Miguel D., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results